Cargando…
The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects
Using simulated viral load data for a given maraviroc monotherapy study design, the feasibility of different algorithms to perform parameter estimation for a pharmacokinetic-pharmacodynamic-viral dynamics (PKPD-VD) model was assessed. The assessed algorithms are the first-order conditional estimatio...
Autores principales: | Chan, Phylinda L. S., Jacqmin, Philippe, Lavielle, Marc, McFadyen, Lynn, Weatherley, Barry |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020311/ https://www.ncbi.nlm.nih.gov/pubmed/21088872 http://dx.doi.org/10.1007/s10928-010-9175-z |
Ejemplares similares
-
Assessment of Maraviroc Exposure–Response Relationship at 48 Weeks in Treatment-Experienced HIV-1–Infected Patients in the MOTIVATE Studies
por: Jacqmin, P, et al.
Publicado: (2013) -
Incidence of CXCR4 tropism and CCR5-tropic resistance in
treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1
and 2 trials
por: Jubb, Becky, et al.
Publicado: (2019) -
Genetic analysis of growth curves using the SAEM algorithm
por: Jaffrézic, Florence, et al.
Publicado: (2006) -
Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis
por: Weatherley, Barry, et al.
Publicado: (2017) -
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
por: Vourvahis, Manoli, et al.
Publicado: (2018)